Main Causes of Painful Intercourse (Dyspareunia)
Dyspareunia in women stems from multiple distinct anatomical and physiological causes that can be systematically categorized by pain location (superficial vs. deep) and underlying pathology, with genitourinary syndrome of menopause (GSM), vulvodynia, pelvic floor dysfunction, and endometriosis representing the most common etiologies.
Classification by Pain Location
The anatomical location of pain provides the critical first diagnostic clue 1, 2, 3:
Superficial (Entry) Dyspareunia
Pain occurring at or near the vaginal opening typically indicates:
Genitourinary Syndrome of Menopause (GSM): The most common cause in peri- and postmenopausal women, characterized by vaginal dryness, loss of elasticity, tissue fragility, and decreased lubrication 1, 2, 4. Clinical signs include vaginal pallor, loss of rugae, introital stenosis, and tissue fissuring 1.
Vulvodynia/Vestibulodynia: Chronic vulvar pain without identifiable cause, often presenting as provoked pain with touch or penetration. The cotton swab test reproduces localized pain at the vestibule 3, 5.
Inadequate Lubrication: May result from insufficient arousal, hormonal changes, or medications (particularly aromatase inhibitors in cancer survivors) 6, 7.
Vaginismus: Involuntary spasm of pelvic floor muscles preventing penetration, identifiable during examination when speculum or finger insertion triggers muscle contraction 3, 5.
Dermatologic Conditions: Lichen sclerosus presents with porcelain-white plaques, ecchymosis, and can cause severe dyspareunia through tissue scarring and introital narrowing 8. Lichen planus and other vulvar dermatoses also contribute.
Postpartum Changes: Tissue trauma, episiotomy scars, and breastfeeding-related hypoestrogenism 3.
Deep Dyspareunia
Pain occurring with deep penetration suggests:
Endometriosis: Pelvic endometrial implants causing pain with deep thrusting, often accompanied by dysmenorrhea and infertility 9, 5.
Pelvic Floor Dysfunction: Hypertonic pelvic floor muscles create tenderness on lateral vaginal wall palpation and deep penetration pain 2, 4. This may coexist with superficial causes.
Adhesions: Post-surgical or post-infectious scarring limiting pelvic mobility 5.
Pelvic Inflammatory Disease: Active or chronic infection causing adnexal tenderness 5.
Pelvic Organ Prolapse: Structural changes altering vaginal anatomy 4.
Urethral/Bladder Disorders: Interstitial cystitis and urethral syndrome may cause pain during intercourse 5.
Cancer Treatment-Related Causes
Cancer survivors face unique dyspareunia risks 10, 6, 7:
Aromatase Inhibitor Therapy: Causes severe vaginal dryness and atrophy in 35-38% of breast cancer survivors 6, 7.
Pelvic Radiation: Creates vaginal stenosis, fibrosis, and loss of tissue elasticity 10.
Chemotherapy: Induces premature menopause with abrupt hormonal changes 6, 7.
Post-Hysterectomy Changes: Anatomical alterations and potential nerve damage 4.
Neurophysiologic Mechanisms
Emerging evidence demonstrates that both peripheral and central sensitization contribute to chronic dyspareunia, with altered nerve fiber density and neuroplasticity perpetuating pain cycles even after initial causes resolve 11. This explains why purely anatomical treatments sometimes fail.
Common Pitfalls in Diagnosis
Critical caveat: Many clinicians assume all postmenopausal dyspareunia is GSM-related, missing coexisting pelvic floor dysfunction, vestibulodynia, or dermatologic conditions 2. The examination must systematically evaluate vulva, vestibule, vagina, and pelvic floor separately, not just assess for atrophy.
Another pitfall: Attributing all dyspareunia to psychological causes. While psychosocial factors perpetuate pain cycles, current evidence strongly supports organic etiologies as primary initiators 5, 11.
Diagnostic Approach
History should distinguish 1, 2:
- Superficial vs. deep pain location
- Provoked (with touch/penetration) vs. spontaneous symptoms
- Primary (lifelong) vs. secondary (acquired) onset
- Associated urinary, dermatologic, or inflammatory symptoms
Physical examination proceeds systematically 1, 2:
- Vulvar inspection: Assess for dermatoses, atrophy signs, fissures, color changes
- Cotton swab test: Identify vestibular pain points
- Single-digit vaginal examination: Assess pelvic floor tone, trigger points, and patient's ability to relax muscles
- Speculum examination: Evaluate vaginal tissue quality, pH, discharge
- Bimanual examination: Palpate for adnexal masses, uterine tenderness, cul-de-sac nodularity
Selective use of vaginal pH testing, imaging for suspected deep pathology, and vulvar biopsy for persistent dermatologic findings may be indicated 4.
The most recent comprehensive guideline emphasizes that GSM symptoms include not only dryness but also burning, irritation, dysuria, urgency, and recurrent UTIs—a constellation often missed when focusing solely on vaginal atrophy 1.